TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/20/24 16:14 | 9/18/24 | VCNX | Vaccinex, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Zauderer Maurice | NY | DOT | P,CEO | M.d | 641 | 5.64 | 0 | 114 | 80 | 255 | I | ||||||||||||||
10/5/23 16:31 | 10/3/23 | VCNX | Vaccinex, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Zauderer Maurice | NY | DOT | P,CEO | P.dm | 510 | 0.9990 | 0 | 510 | 96 | 1,042 | M | ||||||||||||||
1/31/22 16:23 | 1/27/22 | VCNX | Vaccinex, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Zauderer Maurice | NY | DO | P,CEO | P.d | 2,000 | 1.11 | 0 | 1,802 | 106 | 3,503 | I | ||||||||||||||
1/27/20 16:23 | 1/23/20 | VCNX | Vaccinex, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Zauderer Maurice | NY | DOT | P,CEO | P.d | 500 | 5.09 | 0 | 98 | 6 | 1,701 | I | ||||||||||||||
7/31/19 16:31 | 7/30/19 | VCNX | Vaccinex, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Zauderer Maurice | NY | DOT | P,CEO | P.d | 750 | 4.08 | 0 | 184 | 13 | 1,603 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |